Lead Product(s) : Thioridazine
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Hamilton Health Sciences | Juravinski Cancer Centre Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Thioridazine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Leukemia, Myeloid, Acute.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 26, 2014
Lead Product(s) : Thioridazine
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Hamilton Health Sciences | Juravinski Cancer Centre Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
